BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 25480781)

  • 21. Steroid receptor coactivator-2 (SRC-2) coordinates cardiomyocyte paracrine signaling to promote pressure overload-induced angiogenesis.
    Suh JH; Lai L; Nam D; Kim J; Jo J; Taffet GE; Kim E; Kaelber JT; Lee HK; Entman ML; Cooke JP; Reineke EL
    J Biol Chem; 2017 Dec; 292(52):21643-21652. PubMed ID: 29127200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long pentraxin PTX3 exacerbates pressure overload-induced left ventricular dysfunction.
    Suzuki S; Shishido T; Funayama A; Netsu S; Ishino M; Kitahara T; Sasaki T; Katoh S; Otaki Y; Watanabe T; Shibata Y; Mantovani A; Takeishi Y; Kubota I
    PLoS One; 2013; 8(1):e53133. PubMed ID: 23372656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The I{kappa}B kinase {beta}/nuclear factor {kappa}B signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression.
    Hikoso S; Yamaguchi O; Nakano Y; Takeda T; Omiya S; Mizote I; Taneike M; Oka T; Tamai T; Oyabu J; Uno Y; Matsumura Y; Nishida K; Suzuki K; Kogo M; Hori M; Otsu K
    Circ Res; 2009 Jul; 105(1):70-9. PubMed ID: 19478205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.
    Sun M; Chen M; Dawood F; Zurawska U; Li JY; Parker T; Kassiri Z; Kirshenbaum LA; Arnold M; Khokha R; Liu PP
    Circulation; 2007 Mar; 115(11):1398-407. PubMed ID: 17353445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II.
    He Z; Zhang X; Chen C; Wen Z; Hoopes SL; Zeldin DC; Wang DW
    Cardiovasc Res; 2015 Mar; 105(3):304-17. PubMed ID: 25618409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
    Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of NF-kappaB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II.
    Kawano S; Kubota T; Monden Y; Kawamura N; Tsutsui H; Takeshita A; Sunagawa K
    Cardiovasc Res; 2005 Sep; 67(4):689-98. PubMed ID: 15921667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ablation of mineralocorticoid receptors in myocytes but not in fibroblasts preserves cardiac function.
    Lother A; Berger S; Gilsbach R; Rösner S; Ecke A; Barreto F; Bauersachs J; Schütz G; Hein L
    Hypertension; 2011 Apr; 57(4):746-54. PubMed ID: 21321305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure.
    Hamid T; Guo SZ; Kingery JR; Xiang X; Dawn B; Prabhu SD
    Cardiovasc Res; 2011 Jan; 89(1):129-38. PubMed ID: 20797985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response.
    Higashikuni Y; Sainz J; Nakamura K; Takaoka M; Enomoto S; Iwata H; Tanaka K; Sahara M; Hirata Y; Nagai R; Sata M
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):654-61. PubMed ID: 22116099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel role for caspase-activated DNase in the regulation of pathological cardiac hypertrophy.
    Gao L; Huang K; Jiang DS; Liu X; Huang D; Li H; Zhang XD; Huang K
    Hypertension; 2015 Apr; 65(4):871-81. PubMed ID: 25646292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bidirectional regulation of nuclear factor-κB and mammalian target of rapamycin signaling functionally links Bnip3 gene repression and cell survival of ventricular myocytes.
    Dhingra R; Gang H; Wang Y; Biala AK; Aviv Y; Margulets V; Tee A; Kirshenbaum LA
    Circ Heart Fail; 2013 Mar; 6(2):335-43. PubMed ID: 23395931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload.
    Gravning J; Ahmed MS; von Lueder TG; Edvardsen T; Attramadal H
    Int J Cardiol; 2013 Oct; 168(3):2049-56. PubMed ID: 23452880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-kappaB in cardiomyocytes.
    Liang YJ; Lai LP; Wang BW; Juang SJ; Chang CM; Leu JG; Shyu KG
    Cardiovasc Res; 2006 Nov; 72(2):303-12. PubMed ID: 16962085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TAK1 Regulates Myocardial Response to Pathological Stress via NFAT, NFκB, and Bnip3 Pathways.
    Li L; Chen Y; Li J; Yin H; Guo X; Doan J; Molkentin JD; Liu Q
    Sci Rep; 2015 Nov; 5():16626. PubMed ID: 26564789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FAK signalling mediates NF-kappaB activation by mechanical stress in cardiac myocytes.
    Crosara-Alberto DP; Inoue RY; Costa CR
    Clin Chim Acta; 2009 May; 403(1-2):81-6. PubMed ID: 19361463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo.
    Freund C; Schmidt-Ullrich R; Baurand A; Dunger S; Schneider W; Loser P; El-Jamali A; Dietz R; Scheidereit C; Bergmann MW
    Circulation; 2005 May; 111(18):2319-25. PubMed ID: 15870116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II receptor blocker reduces oxidative stress and attenuates hypoxia-induced left ventricular remodeling in apolipoprotein E-knockout mice.
    Yamashita C; Hayashi T; Mori T; Tazawa N; Kwak CJ; Nakano D; Sohmiya K; Okada Y; Kitaura Y; Matsumura Y
    Hypertens Res; 2007 Dec; 30(12):1219-30. PubMed ID: 18344628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload-induced Cardiac Hypertrophy and Remodeling in Male Mice.
    Ye Y; Gong H; Wang X; Wu J; Wang S; Yuan J; Yin P; Jiang G; Li Y; Ding Z; Zhang W; Zhou J; Ge J; Zou Y
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):628-39. PubMed ID: 25806688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paeoniflorin attenuates pressure overload-induced cardiac remodeling via inhibition of TGFβ/Smads and NF-κB pathways.
    Zhou H; Yang HX; Yuan Y; Deng W; Zhang JY; Bian ZY; Zong J; Dai J; Tang QZ
    J Mol Histol; 2013 Jun; 44(3):357-67. PubMed ID: 23417833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.